Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Augmenter of liver regeneration | 0.0036 | 0.0839 | 0.0787 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0094 | 0.3061 | 0.3022 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0455 | 0.2327 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.0158 | 0.5478 | 1 |
Plasmodium falciparum | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0036 | 0.0839 | 1 |
Echinococcus granulosus | lamin | 0.0028 | 0.055 | 0.1796 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0036 | 0.0839 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0127 | 0.4295 | 0.4295 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.053 | 0.053 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0022 | 0.0339 | 0.1107 |
Brugia malayi | MH2 domain containing protein | 0.0127 | 0.4295 | 0.4263 |
Trypanosoma cruzi | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0036 | 0.0839 | 1 |
Trypanosoma brucei | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0036 | 0.0839 | 1 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0036 | 0.0839 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0036 | 0.0839 | 1 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.055 | 0.0496 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0094 | 0.3061 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.055 | 0.1796 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.0158 | 0.5478 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.055 | 0.055 |
Echinococcus granulosus | Aminotransferase class III | 0.0022 | 0.0339 | 0.1107 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.3061 | 0.2818 |
Echinococcus multilocularis | FAD linked sulfhydryl oxidase ALR | 0.0036 | 0.0839 | 0.2741 |
Trichomonas vaginalis | glutaminase, putative | 0.0277 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.055 | 0.055 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.0455 | 0.2327 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0022 | 0.0339 | 0.1107 |
Echinococcus multilocularis | musashi | 0.0028 | 0.055 | 0.1796 |
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.055 | 0.1796 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0094 | 0.3061 | 1 |
Plasmodium vivax | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0036 | 0.0839 | 1 |
Echinococcus granulosus | ornithine aminotransferase | 0.0022 | 0.0339 | 0.1107 |
Schistosoma mansoni | glutaminase | 0.0277 | 1 | 1 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.0158 | 0.5478 | 0.532 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0455 | 0.0455 |
Echinococcus granulosus | FAD linked sulfhydryl oxidase ALR | 0.0036 | 0.0839 | 0.2741 |
Mycobacterium ulcerans | glutaminase | 0.0277 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0094 | 0.3061 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0056 | 0.0056 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.055 | 0.0496 |
Brugia malayi | 4-aminobutyrate aminotransferase, mitochondrial precursor | 0.0022 | 0.0339 | 0.0284 |
Loa Loa (eye worm) | hepatopoietin HPO2 | 0.0036 | 0.0839 | 0.0839 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0094 | 0.3061 | 1 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.0022 | 0.0339 | 0.5 |
Schistosoma mansoni | lamin | 0.0028 | 0.055 | 0.0218 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0455 | 0.0401 |
Loa Loa (eye worm) | glutaminase | 0.0277 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0112 | 0.0056 |
Wolbachia endosymbiont of Brugia malayi | acetylornithine transaminase protein | 0.0022 | 0.0339 | 0.5 |
Onchocerca volvulus | 0.0028 | 0.055 | 0.5 | |
Schistosoma mansoni | lamin | 0.0028 | 0.055 | 0.0218 |
Mycobacterium ulcerans | hypothetical protein | 0.0158 | 0.5478 | 0.532 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0127 | 0.4295 | 0.4295 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0036 | 0.0839 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0455 | 0.2327 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.3061 | 0.2818 |
Mycobacterium leprae | PROBABLE ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE BIOA | 0.0158 | 0.5478 | 1 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0036 | 0.0839 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0277 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0094 | 0.3061 | 0.3061 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.0455 | 0.2327 |
Onchocerca volvulus | 0.0028 | 0.055 | 0.5 | |
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.055 | 0.1796 |
Schistosoma mansoni | intermediate filament proteins | 0.0028 | 0.055 | 0.0218 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.3061 | 0.2818 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.055 | 0.055 |
Echinococcus multilocularis | Aminotransferase class III | 0.0022 | 0.0339 | 0.1107 |
Echinococcus multilocularis | lamin | 0.0028 | 0.055 | 0.1796 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.